Munich – Tuesday, April 28, 2020. Munich-based software start-up Climedo Health has published a Whitepaper named “Impact of COVID-19 on the MedTech Industry“. The paper analyses four major areas that are being significantly affected by the outbreak.
Almost no industry has been left untouched by the Coronavirus outbreak. This clearly includes the MedTech sector, which manufactures many of the vital devices and products in the fight against the virus. Combined with disruptions in global supply chains, the high demand for certain products (personal protective equipment and ventilators), COVID-19 has led to massive shortages in certain areas. This is what the first part of the 12-page report by Climedo Health addresses. The second part analyzes other MedTech sectors which are experiencing a temporary decline in demand due to the pandemic, such as instruments used in elective procedures. Such procedures are currently often postponed for capacity reasons. The report then looks at some innovative diagnostic and treatment examples that could serve as inspiration for companies. Finally, the consequences for the EU Medical Device Regulation (EU-MDR) are considered, which was postponed due to COVID-19, among other things.
“In addition to the dramatic consequences for our society and economy, the crisis has exposed many flaws in our global healthcare system,” says Veronika Schweighart, Co-Founder and COO of Climedo. “What’s interesting, however, is that the virus has served as a wake-up call for many and, in some cases, has accelerated digital transformation in a way that would have taken much longer under normal circumstances. As this will certainly not be our last pandemic, we will hopefully be (even) better prepared next time. With more transparency, more efficient processes and an openness to digital solutions, many of the problems that companies are currently experiencing could be avoided or at least solved more quickly in future.”
The free Whitepaper is now available for download here.
About Climedo Health
Climedo’s mission is to bring the best treatment to every patient by empowering healthcare professionals with intelligent software solutions. Together with Europe’s leading hospitals, they have developed a cloud-based platform for cutting-edge clinical validation of medical devices and pharmaceutical products. By digitally connecting all stakeholders (medical device manufacturers, pharmaceutical companies, CROs, hospitals and patients), Climedo allows for increased performance, better cost-efficiencies – and ultimately – accelerated medical innovation.
You may also be interested in these articles
Catherine | Marketing Lead at Climedo, November 28, 2022
Survey: Patient Centricity, Digital Tools and Reducing Administrative Effort Seen as Top Drivers for Clinical Trial Success
Catherine | Marketing Lead at Climedo, November 14, 2022